Team Building the viral
platform of the future.

The Codagenix team and its founders pioneered the use of codon deoptimization to construct groundbreaking vaccines and virotheraputics. We are now pushing this proven method into the clinic and beyond.

Leadership team

J. Robert Coleman, PhD, MBA

Co-Founder, Chief Executive Officer

Steffen Mueller, PhD

Co-Founder, President & Chief Scientific Officer

Sybil Tasker, MD, MPH, FACP, FIDSA

Chief Medical Officer

Jeffrey Fu, PhD

Chief Business Officer

Tyler Cook

Chief Financial Officer

Johanna Kaufmann, PhD

Executive Vice President for Oncology

Bruce E. Taillon, PhD

Executive Vice President of Animal Health

Test tubes with abstract representation of DNA double helix and sequencing within.

We bring a wealth of experience in virology, computational science and patient care to developing a platform of viral therapeutics and vaccines capable of overcoming our biggest obstacles to global health.